US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Organon & Co

10.63

-0.4900-4.41%

Post-market: 10.700.0700+0.66%19:47 EDT

Volume:4.50M

Turnover:47.88M

Market Cap:2.74B

PE:3.19

High:11.10

Open:11.04

Low:10.45

Close:11.12

Loading ...

Overview Company News Filings

Organon (OGN) Q4 Earnings Report Preview: What To Look For

Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Organon (OGN) and Inventiva (IVA)

Organon & Co : JP Morgan Cuts Target Price to $18 From $20

THOMSON REUTERS

With 79% ownership, Organon & Co. (NYSE:OGN) boasts of strong institutional backing

Simply Wall St.

Organon transferred with a Hold at TD Cowen

FDA approves Organon’s VTAMA cream, 1% for the treatment for AD

Organon Says Vtama Cream Approved by FDA for Atopic Dermatitis

MT Newswires Live

BRIEF-FDA Approves Vtama® Cream, 1% For The Treatment Of Atopic Dermatitis

FDA Approves Vtama® (Tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older

THOMSON REUTERS

BRIEF-FDA Approves Dermavant Science's Vtama For Topical Treatment Of Atopic Dermatitis In Adult & Pediatric Patients 2 Years & Older

FDA: Approves Dermavant Science's Vtama for Topical Treatment of Atopic Dermatitis in Adult & Pediatric Patients 2 Years & Older - Website

THOMSON REUTERS

Earnings Working Against Organon & Co.'s (NYSE:OGN) Share Price

Simply Wall St.

Merck-marketed asthma drug linked to psychiatric issues: report

Organon's (NYSE:OGN) Earnings Are Weaker Than They Seem

Simply Wall St.

Earnings Update: Organon & Co. (NYSE:OGN) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Simply Wall St.

Organon Says FDA Extended Review of VTAMA's Supplemental New Drug Application

MT Newswires Live

Stock Track | Organon Plunges as FDA Delays Review of Atopic Dermatitis Drug VTAMA

Organon: FDA Extends Vtama Atopic-Dermatitis Review to March

Organon updates outlook as FDA delays VTAMA label expansion

Stock Track | Organon Surges as FDA Extends Review for Potential AD Treatment VTAMA

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/OGN/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OGN\",,,,,undefined,":{"symbol":"OGN","market":"US","secType":"STK","nameCN":"Organon & Co","latestPrice":10.63,"timestamp":1745265600000,"preClose":11.12,"halted":0,"volume":4495052,"hourTrading":{"tag":"盘后","latestPrice":10.7,"preClose":10.63,"latestTime":"19:47 EDT","volume":355111,"amount":3775002.0713,"timestamp":1745279252079},"delay":0,"floatShares":256822726,"shares":257950149,"eps":3.33,"marketStatus":"Not Yet Opened","change":-0.49,"latestTime":"04-21 16:00:00 EDT","open":11.04,"high":11.1,"low":10.45,"amount":47877309.040401995,"amplitude":0.058453,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.33,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745308800000},"marketStatusCode":0,"adr":0,"exchange":"NYSE","adjPreClose":11.12,"dividendRate":0.105362,"preHourTrading":{"tag":"盘前","latestPrice":11.15,"preClose":11.12,"latestTime":"09:10 EDT","volume":1045,"amount":11651.50547,"timestamp":1745241011050},"postHourTrading":{"tag":"盘后","latestPrice":10.7,"preClose":10.63,"latestTime":"19:47 EDT","volume":355111,"amount":3775002.0713,"timestamp":1745279252079},"volumeRatio":1.264321,"impliedVol":0.7369,"impliedVolPercentile":0.968},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OGN\",,,,,undefined,":{"symbol":"OGN","floatShares":256822726,"roa":"7.39%","roe":"429.85%","lyrEps":3.361266,"volumeRatio":1.264321,"shares":257950149,"dividePrice":1.12,"high":11.1,"amplitude":0.058453,"preClose":11.12,"low":10.45,"week52Low":10.45,"pbRate":"5.81","psRate":"0.43","week52High":23.1,"institutionHeld":0,"latestPrice":10.63,"eps":3.33,"divideRate":0.105362,"volume":4495052,"delay":0,"ttmEps":3.33,"open":11.04,"prevYearClose":14.92,"prevWeekClose":11.12,"prevMonthClose":14.89,"prevQuarterClose":14.89,"fiveDayClose":11.18,"twentyDayClose":15.39,"sixtyDayClose":16.41,"earningDate":1746028800000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OGN\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2510377871","title":"Organon (OGN) Q4 Earnings Report Preview: What To Look For","url":"https://stock-news.laohu8.com/highlight/detail?id=2510377871","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510377871?lang=en_us&edition=fundamental","pubTime":"2025-02-12 21:05","pubTimestamp":1739365550,"startTime":"0","endTime":"0","summary":"Pharmaceutical company Organon  will be reporting earnings tomorrow before market hours. Here’s what investors should know.Organon beat analysts’ revenue expectations by 1.1% last quarter, reporting revenues of $1.58 billion, up 4.1% year on year. It was a slower quarter for the company, with a miss of analysts’ EPS estimates.Is Organon a buy or sell going into earnings?Read our full analysis here, it’s free.This quarter, analysts are expecting Organon’s revenue to decline 1.2% year on year to $1.58 billion, a reversal from the 7.6% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.87 per share.Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known  semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite se","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/organon-ogn-q4-earnings-report-130550121.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PFE","OGN"],"gpt_icon":1},{"id":"2510325406","title":"Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Organon (OGN) and Inventiva (IVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2510325406","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510325406?lang=en_us&edition=fundamental","pubTime":"2025-02-12 17:33","pubTimestamp":1739352816,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Medtronic (MDT – Research Report), Organon (OGN – Re...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-medtronic-mdt-organon-ogn-and-inventiva-iva?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-medtronic-mdt-organon-ogn-and-inventiva-iva?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0211326839.USD","LU0265550946.USD","LU0162691827.USD","LU2089283258.USD","IE00BQXX3D17.EUR","BK4082","LU2271345857.HKD","BK4007","LU1983299246.USD","LU0072461881.USD","LU2065170008.USD","BK4559","LU0976567544.SGD","OGN","LU2065171311.SGD","LU0158827948.USD","LU2065169927.USD","IE00BQXX3C00.GBP","LU2089984988.USD","LU2111349929.HKD","LU2468319806.SGD","IVA","LU0211326755.USD","LU0158827781.USD","BK4588","LU2065171402.SGD","LU0211331839.USD","LU1989764664.SGD","IE000M9KFDE8.USD","BK4585","LU2023251221.USD","LU1116320737.USD","LU0320765489.SGD","LU2028103732.USD","BK4139","LU0208291251.USD","LU1571399168.USD","HCSG","MDT","IE00BQXX3F31.USD","LU0265550359.USD","LU1291159041.SGD","BK4566","LU0496365809.HKD","IE00B3T34201.USD","BK4137","IE00BFXG1179.USD","BK4533","LU1116320901.HKD","LU1989771016.USD"],"gpt_icon":0},{"id":"2506628345","title":"Organon & Co : JP Morgan Cuts Target Price to $18 From $20","url":"https://stock-news.laohu8.com/highlight/detail?id=2506628345","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506628345?lang=en_us&edition=fundamental","pubTime":"2025-01-27 13:50","pubTimestamp":1737957055,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nFWN3OL0NC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065171402.SGD","BK4559","LU2065169927.USD","BK4585","BK4588","BK4007","LU2065170008.USD","LU2065171311.SGD","OGN"],"gpt_icon":0},{"id":"2506896867","title":"With 79% ownership, Organon & Co. (NYSE:OGN) boasts of strong institutional backing","url":"https://stock-news.laohu8.com/highlight/detail?id=2506896867","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506896867?lang=en_us&edition=fundamental","pubTime":"2025-01-24 19:27","pubTimestamp":1737718061,"startTime":"0","endTime":"0","summary":"Key Insights Significantly high institutional ownership implies Organon's stock price is sensitive to their trading...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-ogn/organon/news/with-79-ownership-organon-co-nyseogn-boasts-of-strong-instit","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2065169927.USD","LU2065170008.USD","BK4588","LU2065171402.SGD","BK4007","NYSE","LU2065171311.SGD","BK4585","BK4559","OGN"],"gpt_icon":0},{"id":"2503868362","title":"Organon transferred with a Hold at TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2503868362","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503868362?lang=en_us&edition=fundamental","pubTime":"2025-01-15 03:15","pubTimestamp":1736882128,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Michael Nedelcovych took over primary coverage of Organon (OGN) with a Hold rating and $19 price target Organon presented business...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/organon-transferred-with-a-hold-at-td-cowen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/organon-transferred-with-a-hold-at-td-cowen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4559","OGN","TD","LU2065169927.USD","BK4207","BK4588","LU2065171402.SGD","LU2065171311.SGD","LU2065170008.USD","BK4127","BK4566","COWN","BK4007","BK4585"],"gpt_icon":0},{"id":"2492951689","title":"FDA approves Organon’s VTAMA cream, 1% for the treatment for AD","url":"https://stock-news.laohu8.com/highlight/detail?id=2492951689","media":"TipRanks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492951689?lang=en_us&edition=fundamental","pubTime":"2024-12-17 20:40","pubTimestamp":1734439239,"startTime":"0","endTime":"0","summary":"Organon  announced that the U.S. Food and Drug Administration or FDA has approved VTAMA or tapinarof cream, 1%, an aryl hydrocarbon receptor agonist, for an additional indication of the topical treatment of atopic dermatitis AD in adults and pediatric patients 2 years of age and older.Organon received the FDA approval prior to its extended target action date PDUFA of March 12. “With the FDA’s approval of VTAMA cream in atopic dermatitis for adults and children as young as 2 years old, there is now a therapy that offers the potential for powerful skin clearance with no label warnings or precautions, contraindications, and no restrictions on duration of use or percentage of body surface area affected,” said Kevin Ali, Organon’s Chief Executive Officer. “Introducing this new first-in-class therapy for AD patients reaffirms Organon’s commitment to addressing areas of high unmet need.” …“Moreover, because the prevalence of itch makes this condition extremely burdensome to patients and their","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/tXfTVJ1OixCCbB5e.FsdJg--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/38a68defd725ddd544390055e985cfb8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/tXfTVJ1OixCCbB5e.FsdJg--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/38a68defd725ddd544390055e985cfb8"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/fda-approves-organon-vtama-cream-124039240.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-approves-organon-vtama-cream-124039240.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4559","BK4588","OGN","LU2065170008.USD","LU2065171402.SGD","BK4007","LU2065171311.SGD","LU2065169927.USD"],"gpt_icon":0},{"id":"2491957216","title":"Organon Says Vtama Cream Approved by FDA for Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2491957216","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491957216?lang=en_us&edition=fundamental","pubTime":"2024-12-16 21:24","pubTimestamp":1734355450,"startTime":"0","endTime":"0","summary":"Organon  said Monday that the US Food and Drug Administration has approved its Vtama cream, 1%, for an additional indication of topical treatment of atopic dermatitis in adults and children at least two years old.The approval of the drug, also called tapinarof, followed pivotal studies in which up to 46% of patients treated with Vtama cream achieved treatment success on the Validated Investigator Global Assessment for AD at week 8, the company said.Organon also said a 48-week long-term extension study showed that most of the patients achieved skin clearance at least once and did not need further treatment for about 80 consecutive days.Vtama cream was approved in 2022 by the FDA for plaque psoriasis in adults.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OGN","BK4588","LU2065170008.USD","BK4007","LU2065169927.USD","LU2065171311.SGD","BK4585","LU2065171402.SGD","BK4559"],"gpt_icon":0},{"id":"2491982536","title":"BRIEF-FDA Approves Vtama® Cream, 1% For The Treatment Of Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2491982536","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491982536?lang=en_us&edition=fundamental","pubTime":"2024-12-16 20:50","pubTimestamp":1734353411,"startTime":"0","endTime":"0","summary":"BRIEF-FDA Approves Vtama® Cream, 1% For The Treatment Of Atopic Dermatitis Dec 16 (Reuters) - Organon & Co OGN.N:FDA APPROVES VTAMA® (TAPINAROF) CREAM, 1% FOR THE TREATMENT OF ATOPIC DERMATITIS IN ADULTS AND CHILDREN 2 YEARS OF AGE AND OLDERSource text: ID:nBw3kvnjJaFurther company coverage: OGN.N","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nTUA42RQFP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065170008.USD","BK4559","LU2065171402.SGD","LU2065171311.SGD","BK4585","BK4007","LU2065169927.USD","BK4588","OGN"],"gpt_icon":0},{"id":"2491660111","title":"FDA Approves Vtama® (Tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older","url":"https://stock-news.laohu8.com/highlight/detail?id=2491660111","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491660111?lang=en_us&edition=fundamental","pubTime":"2024-12-16 20:30","pubTimestamp":1734352200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nTUA42RQFP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LU2065170008.USD","LU2065171402.SGD","OGN","LU2065169927.USD","BK4559","LU2065171311.SGD","BK4585","BK4588"],"gpt_icon":0},{"id":"2491304422","title":"BRIEF-FDA Approves Dermavant Science's Vtama For Topical Treatment Of Atopic Dermatitis In Adult & Pediatric Patients 2 Years & Older","url":"https://stock-news.laohu8.com/highlight/detail?id=2491304422","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491304422?lang=en_us&edition=fundamental","pubTime":"2024-12-14 03:09","pubTimestamp":1734116980,"startTime":"0","endTime":"0","summary":"Dec 13 (Reuters) - FDA:   * FDA: APPROVES DERMAVANT SCIENCE'S VTAMA FOR TOPICAL TREATMENT OF ATOPIC DERMATITIS IN ADULT & PEDIATRIC PATIENTS 2 YEARS & OLDER - WEBSITEFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BRIEF-FDA Approves Dermavant Science's Vtama For Topical Treatment Of Atopic Dermatitis In Adult & Pediatric Patients 2 Years & Older","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065170008.USD","BK4585","BK4007","LU2065171402.SGD","BK4588","OGN","BK4559","LU2065169927.USD","LU2065171311.SGD"],"gpt_icon":0},{"id":"2491304124","title":"FDA: Approves Dermavant Science's Vtama for Topical Treatment of Atopic Dermatitis in Adult & Pediatric Patients 2 Years & Older - Website","url":"https://stock-news.laohu8.com/highlight/detail?id=2491304124","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491304124?lang=en_us&edition=fundamental","pubTime":"2024-12-14 03:08","pubTimestamp":1734116917,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241213:nFWN3NE0T1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065170008.USD","BK4585","LU2065171402.SGD","LU2065171311.SGD","LU2065169927.USD","BK4559","BK4007","BK4588","OGN"],"gpt_icon":0},{"id":"2491305803","title":"Earnings Working Against Organon & Co.'s (NYSE:OGN) Share Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2491305803","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491305803?lang=en_us&edition=fundamental","pubTime":"2024-12-13 21:55","pubTimestamp":1734098132,"startTime":"0","endTime":"0","summary":"Organon & Co.'s ( NYSE:OGN ) price-to-earnings (or \"P/E\") ratio of 3x might make it look like a strong buy right now...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-ogn/organon/news/earnings-working-against-organon-cos-nyseogn-share-price","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NYSE","OGN"],"gpt_icon":0},{"id":"2485317298","title":"Merck-marketed asthma drug linked to psychiatric issues: report","url":"https://stock-news.laohu8.com/highlight/detail?id=2485317298","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485317298?lang=en_us&edition=fundamental","pubTime":"2024-11-22 23:49","pubTimestamp":1732290591,"startTime":"0","endTime":"0","summary":"magicmine/iStock via Getty ImagesA widely used asthma therapy first marketed by Merck (NYSE:MRK) may be associated with severe mental issues, including suicidal thoughts, for some patients, Reuters re","market":"hk","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1305810242/image_1305810242.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1305810242/image_1305810242.jpg?io=getty-c-w750"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4321980-merck-asthma-drug-linked-to-psychiatric-issues","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["LU2106854487.HKD","LU0006306889.USD","LU1116320901.HKD","SG9999013999.USD","LU0965509283.SGD","LU2361044949.HKD","LU1989772840.SGD","LU1066051225.USD","IE00BN8TJ469.HKD","SG9999015341.SGD","IE000M9KFDE8.USD","IE00BLSP4452.SGD","LU0985320562.USD","LU0208291251.USD","LU0861579265.USD","LU0289739699.SGD","LU1989772923.USD","MRK","SG9999014575.USD","LU1066051498.USD","LU2089984988.USD","OGN","LU1116320737.USD","LU0965508806.USD","LU2065169927.USD","LU2461242641.AUD","LU0122379950.USD","LU2065171311.SGD","LU2324357040.USD","SG9999015358.SGD","BK4585","LU0234572021.USD","LU1934455863.HKD","BK4533","LU1941712264.USD","LU2361044865.SGD","BK4007","LU1934455194.USD","LU1941712348.USD","LU1093756325.SGD","BK4588","IE00BBT3K403.USD","LU1061106388.HKD","LU1066053197.SGD","LU2065170008.USD","SG9999014567.USD","LU0211331839.USD","LU0965509101.SGD","IE00BJJMRZ35.SGD","BK4559"],"gpt_icon":0},{"id":"2481083851","title":"Organon's (NYSE:OGN) Earnings Are Weaker Than They Seem","url":"https://stock-news.laohu8.com/highlight/detail?id=2481083851","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481083851?lang=en_us&edition=fundamental","pubTime":"2024-11-08 20:07","pubTimestamp":1731067644,"startTime":"0","endTime":"0","summary":"Despite announcing strong earnings, Organon & Co.'s  stock was sluggish. We did some digging and found some worrying underlying problems.NYSE:OGN Earnings and Revenue History November 8th 2024. Our examination of Organon has focussed on certain factors that can make its earnings look better than they are. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free  collection of companies boasting high return on equity, or  this list of stocks with significant inside","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/_kZOVgp9mzpLivYgIet9SA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8045a103f8959173903f7a11497803b2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/_kZOVgp9mzpLivYgIet9SA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8045a103f8959173903f7a11497803b2"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/organons-nyse-ogn-earnings-weaker-120724181.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NYSE","OGN"],"gpt_icon":0},{"id":"2481639227","title":"Earnings Update: Organon & Co. (NYSE:OGN) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts","url":"https://stock-news.laohu8.com/highlight/detail?id=2481639227","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481639227?lang=en_us&edition=fundamental","pubTime":"2024-11-06 02:26","pubTimestamp":1730831161,"startTime":"0","endTime":"0","summary":"Organon & Co.  shareholders are probably feeling a little disappointed, since its shares fell 3.1% to US$16.92 in the week after its latest quarterly results. Results were roughly in line with estimates, with revenues of US$1.6b and statutory earnings per share of US$3.99. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Organon after the latest results.The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Fortunately, the analysts also reconfirmed their revenue estimates,","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/_kZOVgp9mzpLivYgIet9SA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8045a103f8959173903f7a11497803b2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/_kZOVgp9mzpLivYgIet9SA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8045a103f8959173903f7a11497803b2"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/earnings-organon-co-nyse-ogn-182601112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NYSE","OGN"],"gpt_icon":0},{"id":"2481685843","title":"Organon Says FDA Extended Review of VTAMA's Supplemental New Drug Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2481685843","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481685843?lang=en_us&edition=fundamental","pubTime":"2024-11-05 23:03","pubTimestamp":1730819019,"startTime":"0","endTime":"0","summary":"Organon  said Tuesday that the US Food and Drug Administration has extended its review of the company's supplemental new drug application for VTAMA cream to treat atopic dermatitis in children at least two years old and adults.The extended review postpones the target action date to March 12, 2025 from the original target action date of Dec. 12, according to the company.With the new target action date, Organon said it expects about $125 million revenue contribution from VTAMA and an about 75 basis point headwind to adjusted EBITDA margin in 2025.Organon said the FDA extended the review period after determining that a major amendment to the supplemental new drug application is required based on additional information submitted by the company.The FDA did not raise any safety and efficacy concerns, Organon added.Organon shares were 4.5% lower in recent trading.Price: 16.16, Change: -0.76, Percent Change: -4.49","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2065171402.SGD","LU2065169927.USD","BK4559","BK4585","OGN","BK4007","BK4588","LU2065171311.SGD","LU2065170008.USD"],"gpt_icon":0},{"id":"1114881685","title":"Stock Track | Organon Plunges as FDA Delays Review of Atopic Dermatitis Drug VTAMA","url":"https://stock-news.laohu8.com/highlight/detail?id=1114881685","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114881685?lang=en_us&edition=fundamental","pubTime":"2024-11-05 23:02","pubTimestamp":1730818952,"startTime":"0","endTime":"0","summary":"Shares of Organon & Co.  plummeted by over 5% on Monday after the company announced that the U.S. Food and Drug Administration  has extended the review period for its drug VTAMA  cream for the treatment of atopic dermatitis, a common inflammatory skin condition.The FDA has set a new target action date of March 12, 2025, to complete its review of Organon's supplemental New Drug Application for VTAMA as an atopic dermatitis treatment in adults and children aged 2 years and older. This is a three-m","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["OGN"],"gpt_icon":0},{"id":"2481250656","title":"Organon: FDA Extends Vtama Atopic-Dermatitis Review to March","url":"https://stock-news.laohu8.com/highlight/detail?id=2481250656","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481250656?lang=en_us&edition=fundamental","pubTime":"2024-11-05 21:00","pubTimestamp":1730811600,"startTime":"0","endTime":"0","summary":"Organon said the Food and Drug Administration extended by three months its review of an application seeking expanded approval of the healthcare company's recently acquired skin-care cream Vtama.Organon, which is seeking approval of Vtama as a treatment for atopic dermatitis, said the FDA set a new target action date of March 12 for a decision after requesting the final datasets and clinical-study report from a long-term extension study.The Jersey City, N.J., company picked up Vtama as part of its acquisition of Dermavant Sciences from Roivant Sciences last month and had been expecting a green light in atopic dermatitis by the end of the year.Organon noted that the FDA, which approved Vtama as a treatment for plaque psoriasis in 2022, hasn't raised any concerns regarding the safety and efficacy of Vtama or any concerns regarding the approvability of the new indication.Organon said that as a result of the delay, it now expects Vtama to contribute about $125 million in revenue next year, ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2065171402.SGD","ROIV","BK4559","OGN","BK4588","LU2065169927.USD","LU2065170008.USD","LU2065171311.SGD","BK4585","BK4007"],"gpt_icon":0},{"id":"2481509672","title":"Organon updates outlook as FDA delays VTAMA label expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2481509672","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481509672?lang=en_us&edition=fundamental","pubTime":"2024-11-05 20:53","pubTimestamp":1730811223,"startTime":"0","endTime":"0","summary":"hapabapaOrganon  projected a roughly 75 basis-point headwind to the company’s 2025 EBITDA margin on Tuesday after the FDA delayed a potential label expansion for its skin disorder therapy VTAMA  cream. The Merck  spinoff said that the regulator had assigned March 12, 2025, as the new target action date for the company’s supplemental New Drug Application for VTAMA after adding a standard three-month extension to the prior target action date of December 12, 2024. The decision came after the FDA determined that new data OGN had submitted in response to a regulatory request constituted a major amendment to the sNDA. The once-daily topical treatment already indicated in the U.S. for the autoimmune disease plaque psoriasis is currently under FDA review for those aged two years and older with atopic dermatitis, a skin condition known as eczema. Given the new target action date, the company forecasted an approximately 75 basis point impact on its 2025 EBITDA margin next year and updated its pr","market":"nz","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1413289936/image_1413289936.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1413289936/image_1413289936.jpg?io=getty-c-w750"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4247834-organon-stock-on-watch-fda-delays-vtama-label","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["IE00BFTCPJ56.SGD","LU1430594728.SGD","IE00BJT1NW94.SGD","LU0985320562.USD","LU0106261372.USD","LU1023059063.AUD","LU0265550946.USD","LU1061106388.HKD","IE00B4R5TH58.HKD","LU0234572021.USD","LU0965509283.SGD","BK4585","BK4559","LU0208291251.USD","BK4588","LU0203347892.USD","IE00BLSP4239.USD","LU0122379950.USD","OGN","LU2065171311.SGD","IE00BLSP4452.SGD","LU1093756325.SGD","LU1093756168.USD","LU0965509101.SGD","MRK","LU0238689110.USD","LU0211331839.USD","LU0006306889.USD","LU1291159041.SGD","IE0002141913.USD","LU0289739699.SGD","IE00B2B36J28.USD","LU0861579265.USD","IE000M9KFDE8.USD","LU1934455277.USD","LU0266013472.USD","LU1116320737.USD","LU1934455863.HKD","IE00BBT3K403.USD","BK4516","LU1941712264.USD","LU2065169927.USD","BK4550","LU1066051225.USD","IE00BN8TJ469.HKD","LU1934455194.USD","LU2065171402.SGD","LU1917777945.USD","LU0070302665.USD","LU0965509010.AUD"],"gpt_icon":0},{"id":"1182282045","title":"Stock Track | Organon Surges as FDA Extends Review for Potential AD Treatment VTAMA","url":"https://stock-news.laohu8.com/highlight/detail?id=1182282045","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182282045?lang=en_us&edition=fundamental","pubTime":"2024-11-05 20:36","pubTimestamp":1730810188,"startTime":"0","endTime":"0","summary":"Shares of Organon & Co  soared 6.26% in the past 24 hours following an update on the U.S. Food and Drug Administration's  review process for the company's investigational drug VTAMA  cream, 1% for the treatment of atopic dermatitis  in adults and children aged two and above.The FDA has extended the target action date for reviewing the supplemental New Drug Application  for VTAMA by three months, from December 12, 2024, to March 12, 2025. This extension was triggered by the agency's request for a","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | Organon Surges as FDA Extends Review for Potential AD Treatment VTAMA","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["OGN"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":87,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OGN\",params:#limit:5,,,undefined,":[{"date":"2025-05-01","symbol":"OGN","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":0.86,"defaultRemindTime":1746086400000,"name":null,"time":"Pre-Market","dateTimestamp":1746072000000,"actualEps":null},{"date":"2025-02-24","symbol":"OGN","amount":0.28,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-24","defaultRemindTime":1740407400000,"name":"Organon & Co","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-13","payableDate":"2025-02-24","currency":"USD","dateTimestamp":1740373200000,"payDate":"2025-03-13"},{"market":"US","date":"2025-02-13","symbol":"OGN","fiscalQuarterEnding":"2024/12","expectedEps":0.82,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739422800000,"reportTimeType":"pre","actualEps":0.83},{"date":"2024-11-12","symbol":"OGN","amount":0.28,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-12","defaultRemindTime":1731421800000,"name":"Organon & Co","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-12","payableDate":"2024-11-12","currency":"USD","dateTimestamp":1731387600000,"payDate":"2024-12-12"},{"market":"US","date":"2024-10-31","symbol":"OGN","fiscalQuarterEnding":"2024/09","expectedEps":0.79,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"pre","actualEps":0.81}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OGN\",market:\"US\",,,undefined,":[{"executeDate":"2021-08-20","recordDate":"2021-08-23","paymentDate":"2021-09-13","value":0.28,"currency":"USD"},{"executeDate":"2021-11-19","recordDate":"2021-11-22","paymentDate":"2021-12-16","value":0.28,"currency":"USD"},{"executeDate":"2022-02-25","recordDate":"2022-02-28","paymentDate":"2022-03-17","value":0.28,"currency":"USD"},{"executeDate":"2022-05-13","recordDate":"2022-05-16","paymentDate":"2022-06-16","value":0.28,"currency":"USD"},{"executeDate":"2022-08-12","recordDate":"2022-08-15","paymentDate":"2022-09-15","value":0.28,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.375,"hold":0.25,"sell":0.375,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.25,"analysts":8,"updateTime":1744084800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OGN","date":"2025-04-17","current":3.230348,"percent":0.067921,"low":2.858464,"twenty":4.539542,"median":5.469126,"eighty":6.878815,"high":8.287792,"avg":5.59333,"sd":1.287264,"marketCap":2791020612},"quantilePoints":[{"date":"2021-05-14","current":3.896567,"twenty":3.896567,"median":3.896567,"eighty":3.896567,"marketCap":8416584968},{"date":"2021-05-21","current":4.406344,"twenty":3.996179,"median":4.394625,"eighty":4.406344,"marketCap":9517702100},{"date":"2021-05-28","current":4.189542,"twenty":4.160245,"median":4.33017,"eighty":4.406344,"marketCap":9049410906},{"date":"2021-06-04","current":4.002038,"twenty":4.106103,"median":4.316107,"eighty":4.396969,"marketCap":8644402306},{"date":"2021-06-11","current":3.474683,"twenty":3.656562,"median":4.174893,"eighty":4.394625,"marketCap":7505315618},{"date":"2021-06-18","current":3.513356,"twenty":3.5532,"median":4.002038,"eighty":4.347749,"marketCap":7588848642},{"date":"2021-06-25","current":4.123733,"twenty":3.589061,"median":4.031533,"eighty":4.331342,"marketCap":7653648040},{"date":"2021-07-02","current":4.21525,"twenty":3.665234,"median":4.123733,"eighty":4.31892,"marketCap":7823503760},{"date":"2021-07-09","current":4.111439,"twenty":3.684922,"median":4.114171,"eighty":4.267067,"marketCap":7630831600},{"date":"2021-07-16","current":3.94343,"twenty":3.711407,"median":4.064315,"eighty":4.229455,"marketCap":7319006920},{"date":"2021-07-23","current":4.070462,"twenty":3.829066,"median":4.066364,"eighty":4.224538,"marketCap":7554776800},{"date":"2021-07-30","current":3.962553,"twenty":3.924685,"median":4.056802,"eighty":4.220682,"marketCap":7354499160},{"date":"2021-08-06","current":4.029484,"twenty":3.930317,"median":4.044509,"eighty":4.216686,"marketCap":7478722000},{"date":"2021-08-13","current":4.981495,"twenty":3.946708,"median":4.050656,"eighty":4.220682,"marketCap":8672782360},{"date":"2021-08-20","current":4.83789,"twenty":3.957089,"median":4.062266,"eighty":4.321732,"marketCap":8422766594},{"date":"2021-08-27","current":4.987891,"twenty":3.969929,"median":4.07934,"eighty":4.399313,"marketCap":8683917996},{"date":"2021-09-03","current":5.18595,"twenty":3.974847,"median":4.114171,"eighty":4.832647,"marketCap":9028739266},{"date":"2021-09-10","current":4.934007,"twenty":3.97594,"median":4.132119,"eighty":4.866681,"marketCap":8590106327},{"date":"2021-09-17","current":4.955852,"twenty":3.978671,"median":4.152916,"eighty":4.910706,"marketCap":8628138085},{"date":"2021-09-24","current":4.906337,"twenty":3.985228,"median":4.172906,"eighty":4.908958,"marketCap":8541932768},{"date":"2021-10-01","current":4.85391,"twenty":3.994034,"median":4.212518,"eighty":4.908958,"marketCap":8450656549},{"date":"2021-10-08","current":4.743229,"twenty":3.998523,"median":4.223445,"eighty":4.900512,"marketCap":8257962311},{"date":"2021-10-15","current":5.081095,"twenty":4.004274,"median":4.27524,"eighty":4.903424,"marketCap":8846186829},{"date":"2021-10-22","current":5.193232,"twenty":4.011453,"median":4.33603,"eighty":4.922647,"marketCap":9041416518},{"date":"2021-10-29","current":5.35197,"twenty":4.022108,"median":4.400484,"eighty":4.947405,"marketCap":9317780624},{"date":"2021-11-05","current":5.283524,"twenty":4.029484,"median":4.45322,"eighty":4.985333,"marketCap":9198614450},{"date":"2021-11-12","current":5.632588,"twenty":4.03003,"median":4.749054,"eighty":5.060998,"marketCap":8544635977},{"date":"2021-11-19","current":5.223097,"twenty":4.031943,"median":4.78255,"eighty":5.132066,"marketCap":7923438406},{"date":"2021-11-26","current":5.20304,"twenty":4.033582,"median":4.789832,"eighty":5.18595,"marketCap":7893012402},{"date":"2021-12-03","current":4.818621,"twenty":4.034401,"median":4.79951,"eighty":5.179251,"marketCap":7309847336},{"date":"2021-12-10","current":4.803578,"twenty":4.039045,"median":4.803578,"eighty":5.151872,"marketCap":7287027833},{"date":"2021-12-17","current":5.04593,"twenty":4.045602,"median":4.817333,"eighty":5.143194,"marketCap":7654675375},{"date":"2021-12-23","current":5.050944,"twenty":4.049973,"median":4.823635,"eighty":5.1178,"marketCap":7662281876},{"date":"2021-12-31","current":5.089386,"twenty":4.051339,"median":4.829152,"eighty":5.1178,"marketCap":7720598383},{"date":"2022-01-07","current":5.416979,"twenty":4.062266,"median":4.839346,"eighty":5.18595,"marketCap":8217556439},{"date":"2022-01-14","current":5.492191,"twenty":4.062266,"median":4.85391,"eighty":5.198026,"marketCap":8331653952},{"date":"2022-01-21","current":5.176298,"twenty":4.065544,"median":4.867016,"eighty":5.203991,"marketCap":7852444398},{"date":"2022-01-28","current":5.256525,"twenty":4.069642,"median":4.884984,"eighty":5.203991,"marketCap":7974148412},{"date":"2022-02-04","current":5.535647,"twenty":4.084668,"median":4.898847,"eighty":5.229783,"marketCap":8397576960},{"date":"2022-02-11","current":5.80307,"twenty":4.106795,"median":4.900622,"eighty":5.273377,"marketCap":8803257006},{"date":"2022-02-18","current":6.77322,"twenty":4.113625,"median":4.906337,"eighty":5.293446,"marketCap":9150620546},{"date":"2022-02-25","current":7.05098,"twenty":4.119908,"median":4.910706,"eighty":5.324449,"marketCap":9525874589},{"date":"2022-03-04","current":7.285575,"twenty":4.128765,"median":4.921628,"eighty":5.348475,"marketCap":9842812125},{"date":"2022-03-11","current":6.724425,"twenty":4.132824,"median":4.935463,"eighty":5.378584,"marketCap":9084697539},{"date":"2022-03-18","current":6.583668,"twenty":4.14067,"median":4.952211,"eighty":5.411178,"marketCap":8894535017},{"date":"2022-03-25","current":6.569034,"twenty":4.154382,"median":4.966046,"eighty":5.494865,"marketCap":8874764893},{"date":"2022-04-01","current":6.599072,"twenty":4.160466,"median":4.982791,"eighty":5.52261,"marketCap":8915346841},{"date":"2022-04-08","current":6.734245,"twenty":4.167989,"median":4.995788,"eighty":5.60384,"marketCap":9097965610},{"date":"2022-04-14","current":6.552137,"twenty":4.17956,"median":5.015845,"eighty":5.704124,"marketCap":8851937547},{"date":"2022-04-22","current":6.056503,"twenty":4.19764,"median":5.039484,"eighty":5.803024,"marketCap":8182335394},{"date":"2022-04-29","current":6.069645,"twenty":4.211972,"median":5.050944,"eighty":6.058632,"marketCap":8200089997},{"date":"2022-05-06","current":6.783819,"twenty":4.216686,"median":5.075212,"eighty":6.073577,"marketCap":8818964713},{"date":"2022-05-13","current":6.816987,"twenty":4.220682,"median":5.089386,"eighty":6.132725,"marketCap":8862083034},{"date":"2022-05-20","current":7.343772,"twenty":4.224538,"median":5.111826,"eighty":6.249124,"marketCap":9546903417},{"date":"2022-05-27","current":7.589605,"twenty":4.229455,"median":5.132842,"eighty":6.481977,"marketCap":9866486263},{"date":"2022-06-03","current":7.254023,"twenty":4.25072,"median":5.136185,"eighty":6.547256,"marketCap":9430230315},{"date":"2022-06-10","current":6.918442,"twenty":4.31892,"median":5.164376,"eighty":6.569034,"marketCap":8993974367},{"date":"2022-06-17","current":6.47165,"twenty":4.331342,"median":5.18595,"eighty":6.569034,"marketCap":8413145227},{"date":"2022-06-24","current":6.996484,"twenty":4.33603,"median":5.193232,"eighty":6.583668,"marketCap":9095429238},{"date":"2022-07-01","current":6.682364,"twenty":4.394625,"median":5.202505,"eighty":6.604705,"marketCap":8687073380},{"date":"2022-07-08","current":6.389706,"twenty":4.394625,"median":5.207925,"eighty":6.609211,"marketCap":8306617612},{"date":"2022-07-15","current":6.237524,"twenty":4.404,"median":5.223097,"eighty":6.603203,"marketCap":8108780612},{"date":"2022-07-22","current":6.235572,"twenty":4.420406,"median":5.267389,"eighty":6.599823,"marketCap":8106244240},{"date":"2022-07-29","current":6.188747,"twenty":4.44736,"median":5.280611,"eighty":6.587663,"marketCap":8045371317},{"date":"2022-08-05","current":7.237028,"twenty":4.680567,"median":5.285902,"eighty":6.599823,"marketCap":8011390369},{"date":"2022-08-12","current":7.119857,"twenty":4.742064,"median":5.318366,"eighty":6.631739,"marketCap":7881682144},{"date":"2022-08-19","current":7.044041,"twenty":4.75255,"median":5.333952,"eighty":6.664515,"marketCap":7797753292},{"date":"2022-08-26","current":6.821186,"twenty":4.77119,"median":5.346145,"eighty":6.72327,"marketCap":7551053335},{"date":"2022-09-02","current":6.547788,"twenty":4.781094,"median":5.361158,"eighty":6.72327,"marketCap":7248400810},{"date":"2022-09-09","current":6.853351,"twenty":4.78255,"median":5.379411,"eighty":6.728353,"marketCap":7586659514},{"date":"2022-09-16","current":6.57306,"twenty":4.786919,"median":5.388565,"eighty":6.728353,"marketCap":7276377094},{"date":"2022-09-23","current":5.915983,"twenty":4.79106,"median":5.433693,"eighty":6.723559,"marketCap":6548993714},{"date":"2022-09-30","current":5.376078,"twenty":4.795019,"median":5.450406,"eighty":6.698611,"marketCap":5951318560},{"date":"2022-10-07","current":5.516224,"twenty":4.797113,"median":5.495534,"eighty":6.676511,"marketCap":6106459770},{"date":"2022-10-14","current":5.355401,"twenty":4.799989,"median":5.473806,"eighty":6.672609,"marketCap":5928428873},{"date":"2022-10-21","current":5.440407,"twenty":4.80291,"median":5.469126,"eighty":6.666539,"marketCap":6022530919},{"date":"2022-10-28","current":6.014775,"twenty":4.808437,"median":5.492191,"eighty":6.657079,"marketCap":6658355551},{"date":"2022-11-04","current":6.126383,"twenty":4.814297,"median":5.504727,"eighty":6.648993,"marketCap":6193773359},{"date":"2022-11-11","current":6.367916,"twenty":4.817591,"median":5.516224,"eighty":6.640375,"marketCap":6437963191},{"date":"2022-11-18","current":6.138963,"twenty":4.820626,"median":5.526562,"eighty":6.635494,"marketCap":6206491579},{"date":"2022-11-25","current":6.317597,"twenty":4.8233,"median":5.544315,"eighty":6.633241,"marketCap":6387090309},{"date":"2022-12-02","current":6.722668,"twenty":4.826262,"median":5.573661,"eighty":6.635869,"marketCap":6796617008},{"date":"2022-12-09","current":6.805695,"twenty":4.828278,"median":5.604174,"eighty":6.642253,"marketCap":6880557263},{"date":"2022-12-16","current":6.903817,"twenty":4.832065,"median":5.632588,"eighty":6.668562,"marketCap":6979759382},{"date":"2022-12-23","current":7.0271,"twenty":4.837016,"median":5.685088,"eighty":6.722856,"marketCap":7104397943},{"date":"2022-12-30","current":7.0271,"twenty":4.838473,"median":5.752092,"eighty":6.741307,"marketCap":7104397943},{"date":"2023-01-06","current":7.334048,"twenty":4.840803,"median":5.779739,"eighty":6.752576,"marketCap":7414722522},{"date":"2023-01-13","current":8.066195,"twenty":4.849541,"median":5.80307,"eighty":6.76196,"marketCap":8154922952},{"date":"2023-01-20","current":7.885045,"twenty":4.853036,"median":5.886639,"eighty":6.782258,"marketCap":7971780578},{"date":"2023-01-27","current":7.53281,"twenty":4.859735,"median":5.911388,"eighty":6.797626,"marketCap":7615670405},{"date":"2023-02-03","current":7.487522,"twenty":4.865851,"median":5.943859,"eighty":6.817827,"marketCap":7569884811},{"date":"2023-02-10","current":7.30134,"twenty":4.87589,"median":5.981259,"eighty":6.844798,"marketCap":7381655149},{"date":"2023-02-17","current":7.217625,"twenty":4.883215,"median":6.014775,"eighty":6.899163,"marketCap":6618561922},{"date":"2023-02-24","current":7.098348,"twenty":4.885082,"median":6.02271,"eighty":6.906249,"marketCap":6509185226},{"date":"2023-03-03","current":6.81313,"twenty":4.889255,"median":6.048275,"eighty":6.906249,"marketCap":6247639897},{"date":"2023-03-10","current":6.291603,"twenty":4.896018,"median":6.063022,"eighty":6.904767,"marketCap":5769400361},{"date":"2023-03-17","current":6.011422,"twenty":4.898847,"median":6.061537,"eighty":6.902307,"marketCap":5512473802},{"date":"2023-03-24","current":6.064129,"twenty":4.898972,"median":6.063022,"eighty":6.899698,"marketCap":5560806521},{"date":"2023-03-31","current":6.524626,"twenty":4.900936,"median":6.071417,"eighty":6.886443,"marketCap":5983081856},{"date":"2023-04-06","current":6.557915,"twenty":4.90219,"median":6.080188,"eighty":6.876603,"marketCap":6013607784},{"date":"2023-04-14","current":6.652233,"twenty":4.903849,"median":6.089096,"eighty":6.865757,"marketCap":6100097913},{"date":"2023-04-21","current":6.571785,"twenty":4.906684,"median":6.114299,"eighty":6.849075,"marketCap":6026326921},{"date":"2023-04-28","current":6.767337,"twenty":4.908605,"median":6.136447,"eighty":6.835908,"marketCap":6205648387},{"date":"2023-05-05","current":7.525343,"twenty":4.910706,"median":6.154734,"eighty":6.852323,"marketCap":5613905507},{"date":"2023-05-12","current":7.231308,"twenty":4.913036,"median":6.169544,"eighty":6.900232,"marketCap":5394555949},{"date":"2023-05-19","current":6.998812,"twenty":4.920609,"median":6.176067,"eighty":6.910087,"marketCap":5221113961},{"date":"2023-05-26","current":6.79025,"twenty":4.929638,"median":6.195431,"eighty":6.916101,"marketCap":5065526295},{"date":"2023-06-02","current":6.650068,"twenty":4.934298,"median":6.198502,"eighty":6.912589,"marketCap":4960950979},{"date":"2023-06-09","current":6.841536,"twenty":4.937502,"median":6.209295,"eighty":6.912589,"marketCap":5103785557},{"date":"2023-06-16","current":7.15267,"twenty":4.94624,"median":6.214111,"eighty":6.938687,"marketCap":5335891747},{"date":"2023-06-23","current":7.149251,"twenty":4.94857,"median":6.219474,"eighty":6.960156,"marketCap":5333341129},{"date":"2023-06-30","current":7.087708,"twenty":4.954396,"median":6.23457,"eighty":6.972651,"marketCap":5287430015},{"date":"2023-07-07","current":6.810764,"twenty":4.957751,"median":6.237524,"eighty":6.979666,"marketCap":5080830000},{"date":"2023-07-14","current":7.08087,"twenty":4.963234,"median":6.25344,"eighty":6.981717,"marketCap":5282328780},{"date":"2023-07-21","current":7.145832,"twenty":4.973863,"median":6.266772,"eighty":6.993719,"marketCap":5330790512},{"date":"2023-07-28","current":7.480899,"twenty":4.980527,"median":6.283214,"eighty":7.009926,"marketCap":5580751024},{"date":"2023-08-04","current":7.354394,"twenty":4.983051,"median":6.298006,"eighty":7.022062,"marketCap":5486378177},{"date":"2023-08-11","current":8.00261,"twenty":4.98637,"median":6.34288,"eighty":7.029904,"marketCap":6033968058},{"date":"2023-08-18","current":7.606039,"twenty":4.992629,"median":6.368244,"eighty":7.03947,"marketCap":5734953123},{"date":"2023-08-25","current":7.32471,"twenty":4.99804,"median":6.384829,"eighty":7.061003,"marketCap":5522831416},{"date":"2023-09-01","current":7.443343,"twenty":5.009323,"median":6.401412,"eighty":7.09045,"marketCap":5612280329},{"date":"2023-09-08","current":6.599357,"twenty":5.018519,"median":6.403954,"eighty":7.092056,"marketCap":4975915209},{"date":"2023-09-15","current":6.707821,"twenty":5.029216,"median":6.413118,"eighty":7.091127,"marketCap":5057697072},{"date":"2023-09-22","current":6.297692,"twenty":5.033037,"median":6.41507,"eighty":7.089999,"marketCap":4748459404},{"date":"2023-09-27","current":5.846888,"twenty":5.040773,"median":6.412051,"eighty":7.088624,"marketCap":4408553537},{"date":"2023-10-06","current":5.497769,"twenty":5.04868,"median":6.402566,"eighty":7.083605,"marketCap":4145318166},{"date":"2023-10-13","current":5.640128,"twenty":5.050772,"median":6.394583,"eighty":7.069742,"marketCap":4252656861},{"date":"2023-10-20","current":5.470653,"twenty":5.06117,"median":6.373784,"eighty":7.061003,"marketCap":4124872700},{"date":"2023-10-27","current":5.189325,"twenty":5.067988,"median":6.368244,"eighty":7.060123,"marketCap":3912750994},{"date":"2023-11-03","current":5.727352,"twenty":5.066495,"median":6.367916,"eighty":7.054838,"marketCap":3350500688},{"date":"2023-11-10","current":4.989788,"twenty":5.066495,"median":6.324385,"eighty":7.051487,"marketCap":2919025784},{"date":"2023-11-17","current":4.784429,"twenty":5.049596,"median":6.297692,"eighty":7.045429,"marketCap":2798890747},{"date":"2023-11-24","current":4.963572,"twenty":5.023868,"median":6.291603,"eighty":7.03947,"marketCap":2903689396},{"date":"2023-12-01","current":4.946094,"twenty":4.995136,"median":6.269431,"eighty":7.034371,"marketCap":2893465138},{"date":"2023-12-08","current":4.950464,"twenty":4.989029,"median":6.259729,"eighty":7.033003,"marketCap":2896021203},{"date":"2023-12-15","current":5.601495,"twenty":4.986902,"median":6.239821,"eighty":7.031403,"marketCap":3276874830},{"date":"2023-12-22","current":5.942304,"twenty":4.989029,"median":6.23457,"eighty":7.029904,"marketCap":3476247869},{"date":"2023-12-29","current":6.326806,"twenty":4.990662,"median":6.232836,"eighty":7.029113,"marketCap":3701181555},{"date":"2024-01-05","current":6.020952,"twenty":4.993283,"median":6.23457,"eighty":7.027603,"marketCap":3522257032},{"date":"2024-01-12","current":7.353601,"twenty":4.995462,"median":6.239821,"eighty":7.033003,"marketCap":4301856738},{"date":"2024-01-19","current":6.855496,"twenty":4.99804,"median":6.25344,"eighty":7.034371,"marketCap":4010465373},{"date":"2024-01-26","current":7.357971,"twenty":5.004175,"median":6.266772,"eighty":7.046817,"marketCap":4304412803},{"date":"2024-02-02","current":7.532744,"twenty":5.012413,"median":6.283214,"eighty":7.068727,"marketCap":4406655387},{"date":"2024-02-09","current":7.126396,"twenty":5.021183,"median":6.296221,"eighty":7.088624,"marketCap":4168941378},{"date":"2024-02-16","current":4.652387,"twenty":5.012413,"median":6.296957,"eighty":7.09045,"marketCap":4759392303},{"date":"2024-02-23","current":4.634897,"twenty":4.994809,"median":6.291603,"eighty":7.089083,"marketCap":4741499851},{"date":"2024-03-01","current":4.350598,"twenty":4.98462,"median":6.272091,"eighty":7.084973,"marketCap":4450662036},{"date":"2024-03-08","current":4.555509,"twenty":4.964562,"median":6.260435,"eighty":7.079855,"marketCap":4660285406},{"date":"2024-03-15","current":4.587995,"twenty":4.952619,"median":6.242118,"eighty":7.071929,"marketCap":4693518380},{"date":"2024-03-22","current":4.573001,"twenty":4.943298,"median":6.235071,"eighty":7.061443,"marketCap":4678180084},{"date":"2024-03-28","current":4.610485,"twenty":4.934298,"median":6.225288,"eighty":7.058802,"marketCap":4716525823},{"date":"2024-04-05","current":4.465548,"twenty":4.910706,"median":6.214111,"eighty":7.05301,"marketCap":4568255634},{"date":"2024-04-12","current":4.568003,"twenty":4.903019,"median":6.209295,"eighty":7.049592,"marketCap":4673067319},{"date":"2024-04-19","current":4.463049,"twenty":4.898847,"median":6.198502,"eighty":7.043908,"marketCap":4565699252},{"date":"2024-04-26","current":4.630616,"twenty":4.884689,"median":6.192329,"eighty":7.041987,"marketCap":4737120415},{"date":"2024-05-03","current":4.789749,"twenty":4.859204,"median":6.177041,"eighty":7.035738,"marketCap":5014866889},{"date":"2024-05-10","current":5.037795,"twenty":4.859204,"median":6.174207,"eighty":7.033003,"marketCap":5274571610},{"date":"2024-05-17","current":5.285878,"twenty":4.862356,"median":6.159481,"eighty":7.03247,"marketCap":5534314045},{"date":"2024-05-24","current":5.244121,"twenty":4.869234,"median":6.145607,"eighty":7.030192,"marketCap":5490595021},{"date":"2024-05-31","current":5.143415,"twenty":4.878108,"median":6.131415,"eighty":7.029616,"marketCap":5385155023},{"date":"2024-06-07","current":5.077095,"twenty":4.884492,"median":6.103438,"eighty":7.0271,"marketCap":5315718927},{"date":"2024-06-14","current":5.037795,"twenty":4.885279,"median":6.089096,"eighty":7.0271,"marketCap":5274571610},{"date":"2024-06-21","current":5.023058,"twenty":4.887766,"median":6.086541,"eighty":7.026539,"marketCap":5259141367},{"date":"2024-06-28","current":5.057445,"twenty":4.889293,"median":6.077754,"eighty":7.026165,"marketCap":5295145268},{"date":"2024-07-05","current":4.98867,"twenty":4.891278,"median":6.073189,"eighty":7.020695,"marketCap":5223137465},{"date":"2024-07-12","current":5.128677,"twenty":4.892656,"median":6.063576,"eighty":7.016661,"marketCap":5369724779},{"date":"2024-07-15","current":5.23184,"twenty":4.892876,"median":6.063022,"eighty":7.015995,"marketCap":5477736485},{"date":"2024-08-02","current":5.317809,"twenty":4.893367,"median":6.062188,"eighty":7.015978,"marketCap":5567746239},{"date":"2024-08-09","current":5.036181,"twenty":4.893367,"median":6.060052,"eighty":7.015908,"marketCap":5036181210},{"date":"2024-08-16","current":5.206114,"twenty":4.896035,"median":6.039186,"eighty":7.014411,"marketCap":5206113704},{"date":"2024-08-23","current":5.378621,"twenty":4.898847,"median":6.02271,"eighty":7.007926,"marketCap":5378620934},{"date":"2024-08-30","current":5.744233,"twenty":4.898889,"median":6.016486,"eighty":7.004513,"marketCap":5744233271},{"date":"2024-09-06","current":5.499633,"twenty":4.899055,"median":6.013098,"eighty":6.998812,"marketCap":5499633468},{"date":"2024-09-13","current":5.224137,"twenty":4.90219,"median":5.969811,"eighty":6.998812,"marketCap":5224136848},{"date":"2024-09-20","current":5.195815,"twenty":4.90219,"median":5.950598,"eighty":6.996484,"marketCap":5195814765},{"date":"2024-09-27","current":4.935767,"twenty":4.90219,"median":5.94207,"eighty":6.991876,"marketCap":4935766554},{"date":"2024-10-04","current":4.701466,"twenty":4.89972,"median":5.921803,"eighty":6.985136,"marketCap":4701465690},{"date":"2024-10-11","current":4.629373,"twenty":4.895332,"median":5.906794,"eighty":6.981717,"marketCap":4629373116},{"date":"2024-10-18","current":4.541832,"twenty":4.885476,"median":5.885406,"eighty":6.981717,"marketCap":4541832134},{"date":"2024-10-25","current":4.433693,"twenty":4.861191,"median":5.860446,"eighty":6.978298,"marketCap":4433693273},{"date":"2024-10-31","current":4.616499,"twenty":4.849278,"median":5.836719,"eighty":6.977591,"marketCap":4616499442},{"date":"2024-11-08","current":3.191027,"twenty":4.837599,"median":5.806685,"eighty":6.972651,"marketCap":4151526665},{"date":"2024-11-15","current":3.030684,"twenty":4.824637,"median":5.785429,"eighty":6.97071,"marketCap":3942920176},{"date":"2024-11-22","current":2.947543,"twenty":4.818243,"median":5.774058,"eighty":6.968537,"marketCap":3834753848},{"date":"2024-11-29","current":3.141539,"twenty":4.813679,"median":5.757525,"eighty":6.96331,"marketCap":4087141946},{"date":"2024-12-06","current":3.080173,"twenty":4.799989,"median":5.748592,"eighty":6.958054,"marketCap":4007304895},{"date":"2024-12-13","current":3.038602,"twenty":4.79106,"median":5.742774,"eighty":6.955143,"marketCap":3953221731},{"date":"2024-12-20","current":2.858464,"twenty":4.783334,"median":5.727352,"eighty":6.950007,"marketCap":3718861355},{"date":"2024-12-27","current":2.959421,"twenty":4.763035,"median":5.715098,"eighty":6.943968,"marketCap":3850206181},{"date":"2025-01-03","current":2.9614,"twenty":4.738569,"median":5.688534,"eighty":6.938687,"marketCap":3852781570},{"date":"2025-01-10","current":3.167273,"twenty":4.701466,"median":5.681642,"eighty":6.937269,"marketCap":4120622000},{"date":"2025-01-17","current":3.202905,"twenty":4.674875,"median":5.640536,"eighty":6.930431,"marketCap":4166978997},{"date":"2025-01-24","current":3.248434,"twenty":4.66027,"median":5.631842,"eighty":6.922225,"marketCap":4226212938},{"date":"2025-01-31","current":3.161334,"twenty":4.640892,"median":5.605846,"eighty":6.918788,"marketCap":4112895833},{"date":"2025-02-07","current":2.947543,"twenty":4.630473,"median":5.590299,"eighty":6.91376,"marketCap":3834753848},{"date":"2025-02-14","current":4.864623,"twenty":4.626977,"median":5.572338,"eighty":6.912589,"marketCap":4203034440},{"date":"2025-02-21","current":4.676834,"twenty":4.621405,"median":5.552983,"eighty":6.908835,"marketCap":4040784948},{"date":"2025-02-28","current":4.483084,"twenty":4.616931,"median":5.530836,"eighty":6.906249,"marketCap":3873384680},{"date":"2025-03-07","current":4.436504,"twenty":4.610485,"median":5.521496,"eighty":6.904767,"marketCap":3833139214},{"date":"2025-03-14","current":4.466359,"twenty":4.605995,"median":5.518522,"eighty":6.903374,"marketCap":3858934229},{"date":"2025-03-21","current":4.657433,"twenty":4.605995,"median":5.507234,"eighty":6.903079,"marketCap":4024022324},{"date":"2025-03-28","current":4.346938,"twenty":4.585996,"median":5.499255,"eighty":6.902012,"marketCap":3755754169},{"date":"2025-04-04","current":4.314097,"twenty":4.569713,"median":5.492191,"eighty":6.899698,"marketCap":3727379653},{"date":"2025-04-11","current":3.412466,"twenty":4.556765,"median":5.47223,"eighty":6.886939,"marketCap":2948370203},{"date":"2025-04-17","current":3.230348,"twenty":4.539542,"median":5.469126,"eighty":6.878815,"marketCap":2791020612}],"updateTime":1745262290386}}}